Searched for
OBESITY MARKET
Wegovy maker Novo Nordisk faces investor pressure to find growth beyond weight-loss drugsFacing increased scrutiny, Novo Nordisk must clarify its future strategy outside of its leading weight-loss drug. Investors are advocating ...- BRICS adopts New Delhi Declaration: Inside the 140-point document on Global South's ambitionsBRICS leaders adopted the New Delhi Declaration at the 18th summit, reaffirming their commitment to cooperation, multilateralism and a more...
- Sandoz bets big on biosimilars, aims to double group sales by 2035Sandoz plans to more than double annual net sales by 2035, with biosimilars leading growth. The company will expand its biosimilar portfoli...
- RPG Life Sciences to deploy Rs 500 crore in next 12 months to bolster manufacturing, API capabilitiesRPG Life Sciences plans to deploy Rs 500 crore over the next 12 months to expand manufacturing and API capabilities through strategic acqui...
- Let's know what we eat: The type of front-of-pack labels consumers actually needAs India confronts a rising tide of obesity and associated health conditions, the clarity of front-of-pack labelling is becoming crucial. L...
- From hunger to obesity: Developing world faces growing threat to child healthChildhood obesity is rapidly increasing in developing nations, creating a significant health challenge. This epidemic is now outpacing unde...
- Too weak, too strict: India's food warning labels draw fire from all sidesIndia’s proposed front-of-pack warning labels are facing opposition from both health activists and food companies. FSSAI has proposed a red...
- Eli Lilly’s Mounjaro wins FDA approval for a major new cardiovascular benefitEli Lilly's Mounjaro received FDA approval for reducing heart attack and stroke risks. This new indication expands its use beyond diabetes ...
- 'Put food warning labels on the front': Supreme Court asks Centre to match international food safety standards as obesity is rising among childrenThe Supreme Court has asked the Centre to consider front-of-pack warning labels on junk food amid rising obesity among children. The bench ...
- India wanted red flags on chip packets and soda. Big Food fought backIndia’s food regulator has dropped plans for colour-coded front-of-pack nutrition warnings after industry opposition, opting instead for si...
- Widening waistline: India's big, fat obesity hotspots may not be just the biggest cities anymoreIndia sees a significant rise in overweight and obese populations recently. Rural areas show a particularly sharp increase in these health ...
- UK first in Europe to approve Eli Lilly oral weight loss drugBritain has become the first country in Europe to approve orforglipron, the oral weight loss and diabetes treatment developed by US company...
- Eli Lilly’s Foundayo becomes first oral weight-loss drug approved in UK for diabetesBritain's regulator approved Eli Lilly's Foundayo pill for weight and diabetes. This treatment is not yet available through the NHS in the ...
- Global Market: European shares climb as earnings, US-Iran diplomacy lift sentimentEuropean stocks advanced on Wednesday, driven by U.S.-Iran diplomatic talks. Mining companies led the rally as geopolitical concerns eased ...
- Novo CEO says setbacks demand faster research, acquisitions as investors fret over pipelineNovo Nordisk CEO Mike Doustdar said the company will speed up research and pursue smaller acquisitions to strengthen its drug pipeline afte...
- Drugmaker Pfizer beats earnings estimates, targets $2.5 billion in additional cost cutsPfizer has reported impressive second-quarter earnings, driven by the success of Eliquis and newly acquired pharmaceutical products. The co...
- For GLP-1 users, the in-store clothes shopping trip is backMany consumers using weight-loss drugs are now shopping more in physical stores. Sizing changes prompt shoppers to try on clothes, increasi...
- GLP-1 demand stirs up hunger for obesity care talentDemand for nutrition professionals is rapidly rising across India. Hospitals and digital health platforms are hiring more dietitians and ed...
- US market drag keeps Dr Reddy's, Cipla under pressure despite strong product pipelineIndian pharmaceutical firms experienced a challenging June quarter, marked by declining US business profits. Dr Reddy's and Cipla saw signi...
- Cipla in no hurry to launch semaglutide as Yurpeak gains tractionCipla is focusing on its tirzepatide brand Yurpeak in India's obesity market. Yurpeak has become the second largest GLP-1 product since its...
Load More
